After Glaxo's genital herpes vaccine flop, check out Agenus Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : After Glaxo's genital herpes vaccine flop, check out Agenus

GSK 46.86

-0.2%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: albertaft who wrote (11)	1/23/2015 2:25:07 PM
From: robert b furman	of 22

Glaxo shipping its first batch of EBOLA vaccine. If this is found to be aeffective - could be powerful! Minkoff, SA News EditorThe first batch of GlaxoSmithKline's (NYSE: GSK) experimental Ebola vaccine has been shipped to West Africa and is expected to arrive in Liberia later today.While it is currently being tested in five small phase I safety trials in Britain, the U.S., Switzerland and Mali, the vaccine will be used in the first large-scale trials in the coming weeks.The World Health Organization said on Thursday that the Ebola outbreak in West Africa appears to be waning but still cautioned against its risks.f

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next